Published in Biomaterials on July 16, 2009
Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. Mol Pharm (2012) 1.22
Multi-stimuli responsive macromolecules and their assemblies. Chem Soc Rev (2013) 1.21
A reducible polycationic gene vector derived from thiolated low molecular weight branched polyethyleneimine linked by 2-iminothiolane. Biomaterials (2010) 1.04
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy. Biomaterials (2013) 0.97
Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics delivery. Biomaterials (2011) 0.95
Discovery of cationic polymers for non-viral gene delivery using combinatorial approaches. Comb Chem High Throughput Screen (2011) 0.89
Bioreducible polymers for therapeutic gene delivery. J Control Release (2014) 0.87
Polymeric nucleic acid carriers: current issues and novel design approaches. J Control Release (2012) 0.84
Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system. J Control Release (2011) 0.83
Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery. Biomaterials (2014) 0.82
A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid. Int J Nanomedicine (2012) 0.82
Functional polymers of gene delivery for treatment of myocardial infarct. J Control Release (2014) 0.80
The effect of environmental pH on polymeric transfection efficiency. Biomaterials (2011) 0.79
EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets. J Control Release (2011) 0.78
Poly(ethylenimine) conjugated bioreducible dendrimer for efficient gene delivery. J Control Release (2015) 0.77
Bioreducible polymers as a determining factor for polyplex decomplexation rate and transfection. Biomacromolecules (2013) 0.77
Synthesis of the first poly(diaminosulfide)s and an investigation of their applications as drug delivery vehicles. Macromolecules (2012) 0.76
Reducible chimeric polypeptide consisting of octa-D-arginine and tetra-L-histidine peptides as an efficient gene delivery vector. Int J Nanomedicine (2015) 0.76
RNA interference-based nanosystems for inflammatory bowel disease therapy. Int J Nanomedicine (2016) 0.75
Promising gene delivery system based on polyethylenimine-modified silica nanoparticles. Cancer Gene Ther (2017) 0.75
Screening nylon-3 polymers, a new class of cationic amphiphiles, for siRNA delivery. Mol Pharm (2014) 0.75
One-pot Synthesis of Functional Poly(amino ester sulfide)s and Utility in Delivering pDNA and siRNA. Polymer (Guildf) (2015) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Design and development of polymers for gene delivery. Nat Rev Drug Discov (2005) 6.79
Glutathione metabolism and its implications for health. J Nutr (2004) 6.27
Gene therapy -- promises, problems and prospects. Nature (1997) 6.02
Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem (2003) 4.40
Nonviral vectors for gene delivery. Chem Rev (2009) 4.08
Current status of polymeric gene delivery systems. Adv Drug Deliv Rev (2006) 3.04
Polymers for gene delivery across length scales. Nat Mater (2006) 2.79
A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 2.06
Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2002) 2.00
Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol (2003) 1.92
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
Nonviral gene therapy: promises and challenges. Gene Ther (2000) 1.65
Rapid optimization of gene delivery by parallel end-modification of poly(beta-amino ester)s. Mol Ther (2007) 1.59
Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem (2007) 1.56
Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. J Am Chem Soc (2002) 1.47
Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43
A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release (2003) 1.39
Key issues in non-viral gene delivery. Adv Drug Deliv Rev (2001) 1.32
Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity. J Am Chem Soc (2008) 1.30
A PEG-based biocompatible block catiomer with high buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cells. ChemMedChem (2006) 1.28
Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release (2006) 1.26
Visualization of the degradation of a disulfide polymer, linear poly(ethylenimine sulfide), for gene delivery. Bioconjug Chem (2007) 1.22
Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J Control Release (2007) 1.21
Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents. Int J Nanomedicine (2006) 1.19
A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. J Control Release (2005) 1.16
Gene delivery properties of end-modified poly(beta-amino ester)s. Bioconjug Chem (2007) 1.11
Transfection study using multicellular tumor spheroids for screening non-viral polymeric gene vectors with low cytotoxicity and high transfection efficiencies. J Control Release (2007) 1.08
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
Combinatorial evaluation of cations, pH-sensitive and hydrophobic moieties for polymeric vector design. Mol Ther (2009) 0.94
Effect of chemical functionalities in poly(amido amine)s for non-viral gene transfection. J Control Release (2008) 0.91
Structure-function relationships of gene delivery vectors in a limited polycation library. J Control Release (2005) 0.91
Full orthogonality between Dde and Fmoc: the direct synthesis of PNA--peptide conjugates. Org Lett (2004) 0.90
Poly[Lys-(AEDTP)]: a cationic polymer that allows dissociation of pDNA/cationic polymer complexes in a reductive medium and enhances polyfection. Bioconjug Chem (2002) 0.88
Characterizing the structure/function parameter space of hydrocarbon-conjugated branched polyethylenimine for DNA delivery in vitro. J Control Release (2006) 0.88
Random and block copolymers of bioreducible poly(amido amine)s with high- and low-basicity amino groups: study of DNA condensation and buffer capacity on gene transfection. J Control Release (2007) 0.83
Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery. Biochim Biophys Acta (2000) 0.83
Overcoming limiting side reactions associated with an NHS-activated precursor of polymethacrylamide-based polymers. Bioconjug Chem (2007) 0.83
A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery. J Control Release (2007) 0.80
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell (2008) 4.32
Current status of polymeric gene delivery systems. Adv Drug Deliv Rev (2006) 3.04
Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg (2003) 2.73
Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2005) 2.62
Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev (2002) 2.54
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release (2008) 2.15
Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant (2009) 1.91
Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res (2005) 1.91
Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther (2006) 1.79
Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem (2006) 1.77
In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release (2008) 1.67
Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. Kidney Int (2004) 1.56
Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials (2008) 1.55
Validation of a multi-frequency electrical impedance tomography (mfEIT) system KHU Mark1: impedance spectroscopy and time-difference imaging. Physiol Meas (2008) 1.50
Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res (2008) 1.46
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release (2006) 1.44
Multilevel surgery in patients with rapid eye movement-related obstructive sleep apnea. Otolaryngol Head Neck Surg (2009) 1.43
Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43
Magnetic resonance imaging (MRI) assessment of ventricular remodeling after myocardial infarction in rabbits. Comp Med (2012) 1.42
L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial. Endocr J (2016) 1.40
Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release (2004) 1.34
Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg (2007) 1.25
VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharm (2009) 1.21
Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res (2005) 1.20
Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release (2002) 1.19
Effects of PEG conjugation on insulin properties. Adv Drug Deliv Rev (2002) 1.18
Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int J Pharm (2008) 1.13
Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules (2002) 1.12
An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol Ther (2002) 1.11
Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training. J Thorac Cardiovasc Surg (2009) 1.10
Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. Angew Chem Int Ed Engl (2012) 1.09
Novel pH sensitive block copolymer micelles for solvent free drug loading. Macromol Biosci (2006) 1.08
Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J Control Release (2006) 1.06
Evolution of oncolytic adenovirus for cancer treatment. Adv Drug Deliv Rev (2011) 1.04
The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials (2009) 1.04
Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy. J Control Release (2007) 1.02
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release (2007) 1.02
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis. J Control Release (2005) 1.01
Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res (2004) 1.01
Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials (2005) 1.01
A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems. Biomaterials (2009) 1.00
Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes. Mol Ther (2005) 0.99
Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol Pharm (2009) 0.98
Ligation of the left circumflex coronary artery with subsequent MRI and histopathology in rabbits. J Am Assoc Lab Anim Sci (2010) 0.98
Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin. Biomaterials (2004) 0.97
Synthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrier. J Control Release (2004) 0.97
Mixtures of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)-g-poly(ethylene glycol) for improved gene delivery. Bioconjug Chem (2010) 0.97
Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem (2006) 0.97
Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials (2010) 0.96
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction. J Control Release (2008) 0.96
A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J Control Release (2003) 0.96
Caprolactonic poloxamer analog: PEG-PCL-PEG. Biomacromolecules (2005) 0.96
Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA. Biomaterials (2011) 0.96
GLP-1 gene delivery for the treatment of type 2 diabetes. Mol Ther (2003) 0.95
Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery. Biomaterials (2011) 0.95
Feasibility of breast cancer lesion detection using a multi-frequency trans-admittance scanner (TAS) with 10 Hz to 500 kHz bandwidth. Physiol Meas (2007) 0.95
Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J Control Release (2002) 0.94
Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjug Chem (2003) 0.94
Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system. Spine (Phila Pa 1976) (2005) 0.94
Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials (2010) 0.94
Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J Gene Med (2003) 0.94
LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem (2008) 0.93
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant (2009) 0.93
Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials (2008) 0.92
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Mol Ther (2004) 0.92
A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. J Control Release (2008) 0.92
Dendrimer type bio-reducible polymer for efficient gene delivery. J Control Release (2012) 0.92
Efficient gene expression system using the RTP801 promoter in the corpus cavernosum of high-cholesterol diet-induced erectile dysfunction rats for gene therapy. J Sex Med (2008) 0.91
Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials (2011) 0.91
Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J Surg Res (2007) 0.91
Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Bioconjug Chem (2013) 0.90
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules (2005) 0.90
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials (2011) 0.90
Antiinflammatory activity of Synurus deltoides. Phytother Res (2004) 0.90
Metabolically active human brown adipose tissue derived stem cells. Stem Cells (2014) 0.90
Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol Head Neck Surg (2013) 0.90
A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution. Pharm Res (2005) 0.90
Intracellular kinetics of non-viral gene delivery using polyethylenimine carriers. Pharm Res (2007) 0.90
Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm (2006) 0.90
The results of vestibular evoked myogenic potentials, with consideration of age-related changes, in vestibular neuritis, benign paroxysmal positional vertigo, and Meniere's disease. Acta Otolaryngol (2008) 0.89
Modified linear polyethylenimine-cholesterol conjugates for DNA complexation. Bioconjug Chem (2003) 0.89
Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation. J Control Release (2009) 0.88
Bioreducible polymers with cell penetrating and endosome buffering functionality for gene delivery systems. J Control Release (2011) 0.88
Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion. J Control Release (2012) 0.88